125 related articles for article (PubMed ID: 27298015)
21. The Role of microRNA-23a-3p in the Progression of Human Aging Process by Targeting FOXO3a.
Wang S; Sun Y; Yao L; Xing Y; Yang H; Ma Q
Mol Biotechnol; 2024 Feb; 66(2):277-287. PubMed ID: 37087718
[TBL] [Abstract][Full Text] [Related]
22. Grpel2 maintains cardiomyocyte survival in diabetic cardiomyopathy through DLST-mediated mitochondrial dysfunction: a proof-of-concept study.
Yang R; Zhang X; Zhang Y; Wang Y; Li M; Meng Y; Wang J; Wen X; Yu J; Chang P
J Transl Med; 2023 Mar; 21(1):200. PubMed ID: 36927450
[TBL] [Abstract][Full Text] [Related]
23. A Promising Strategy to Treat Neurodegenerative Diseases by SIRT3 Activation.
Tyagi A; Pugazhenthi S
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675125
[TBL] [Abstract][Full Text] [Related]
24. Emerging role of mitophagy in heart failure: from molecular mechanism to targeted therapy.
Liu Y; Wang Y; Bi Y; Zhao Z; Wang S; Lin S; Yang Z; Wang X; Mao J
Cell Cycle; 2023 Apr; 22(8):906-918. PubMed ID: 36658777
[TBL] [Abstract][Full Text] [Related]
25. Novel insights into the involvement of mitochondrial fission/fusion in heart failure: From molecular mechanisms to targeted therapies.
Liu X; Guo C; Zhang Q
Cell Stress Chaperones; 2023 Mar; 28(2):133-144. PubMed ID: 36652120
[TBL] [Abstract][Full Text] [Related]
26. Omentin1 ameliorates myocardial ischemia-induced heart failure via SIRT3/FOXO3a-dependent mitochondrial dynamical homeostasis and mitophagy.
Hu J; Liu T; Fu F; Cui Z; Lai Q; Zhang Y; Yu B; Liu F; Kou J; Li F
J Transl Med; 2022 Oct; 20(1):447. PubMed ID: 36192726
[TBL] [Abstract][Full Text] [Related]
27. Recent advances in the pharmacological therapy of chronic heart failure: Evidence and guidelines.
Tsutsui H
Pharmacol Ther; 2022 Oct; 238():108185. PubMed ID: 35413307
[TBL] [Abstract][Full Text] [Related]
28. Epicardial adipose tissue in contemporary cardiology.
Iacobellis G
Nat Rev Cardiol; 2022 Sep; 19(9):593-606. PubMed ID: 35296869
[TBL] [Abstract][Full Text] [Related]
29. Electrical management of heart failure: from pathophysiology to treatment.
Prinzen FW; Auricchio A; Mullens W; Linde C; Huizar JF
Eur Heart J; 2022 May; 43(20):1917-1927. PubMed ID: 35265992
[TBL] [Abstract][Full Text] [Related]
30. Effect of Sirt3 on retinal pigment epithelial cells in high glucose through Foxo3a/ PINK1-Parkin pathway mediated mitophagy.
Huang L; Yao T; Chen J; Zhang Z; Yang W; Gao X; Dan Y; He Y
Exp Eye Res; 2022 May; 218():109015. PubMed ID: 35240195
[TBL] [Abstract][Full Text] [Related]
31. Mdivi-1 alleviates cardiac fibrosis post myocardial infarction at infarcted border zone, possibly via inhibition of Drp1-Activated mitochondrial fission and oxidative stress.
Ding J; Zhang Z; Li S; Wang W; Du T; Fang Q; Wang Y; Wang DW
Arch Biochem Biophys; 2022 Mar; 718():109147. PubMed ID: 35143784
[TBL] [Abstract][Full Text] [Related]
32. Omentin-1: a newly discovered warrior against metabolic related diseases.
Zhao A; Xiao H; Zhu Y; Liu S; Zhang S; Yang Z; Du L; Li X; Niu X; Wang C; Yang Y; Tian Y
Expert Opin Ther Targets; 2022 Mar; 26(3):275-289. PubMed ID: 35107051
[TBL] [Abstract][Full Text] [Related]
33. A New Biomarker Tool for Risk Stratification in "
Agra-Bermejo RM; Cacho-Antonio C; Gonzalez-Babarro E; Rozados-Luis A; Couselo-Seijas M; Gómez-Otero I; Varela-Román A; López-Canoa JN; Gómez-Rodríguez I; Pata M; Eiras S; González-Juanatey JR
Front Physiol; 2021; 12():736245. PubMed ID: 35095543
[No Abstract] [Full Text] [Related]
34. Aminoacylase-1 plays a key role in myocardial fibrosis and the therapeutic effects of 20(S)-ginsenoside Rg3 in mouse heart failure.
Lai Q; Liu FM; Rao WL; Yuan GY; Fan ZY; Zhang L; Fu F; Kou JP; Yu BY; Li F
Acta Pharmacol Sin; 2022 Aug; 43(8):2003-2015. PubMed ID: 34916608
[TBL] [Abstract][Full Text] [Related]
35. Relationship between circulating serum omentin-1 levels and nascent metabolic syndrome in patients with hypertension.
Cetin Sanlialp S; Nar G; Nar R
J Investig Med; 2022 Mar; 70(3):780-785. PubMed ID: 34857627
[TBL] [Abstract][Full Text] [Related]
36. LncDACH1 promotes mitochondrial oxidative stress of cardiomyocytes by interacting with sirtuin3 and aggravates diabetic cardiomyopathy.
Zhang Q; Li D; Dong X; Zhang X; Liu J; Peng L; Meng B; Hua Q; Pei X; Zhao L; Hu X; Zhang Y; Pan Z; Lu Y; Yang B
Sci China Life Sci; 2022 Jun; 65(6):1198-1212. PubMed ID: 34668131
[TBL] [Abstract][Full Text] [Related]
37. Role of GTPase-Dependent Mitochondrial Dynamins in Heart Diseases.
Liu J; Song X; Yan Y; Liu B
Front Cardiovasc Med; 2021; 8():720085. PubMed ID: 34660720
[TBL] [Abstract][Full Text] [Related]
38. AMPK-mTOR Signaling and Cellular Adaptations in Hypoxia.
Chun Y; Kim J
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575924
[TBL] [Abstract][Full Text] [Related]
39. Mitochondrial proteins in heart failure: The role of deacetylation by SIRT3.
Wang C; Wang Y; Shen L
Pharmacol Res; 2021 Oct; 172():105802. PubMed ID: 34363948
[TBL] [Abstract][Full Text] [Related]
40. Targeting Mitochondrial Biogenesis with Polyphenol Compounds.
Chodari L; Dilsiz Aytemir M; Vahedi P; Alipour M; Vahed SZ; Khatibi SMH; Ahmadian E; Ardalan M; Eftekhari A
Oxid Med Cell Longev; 2021; 2021():4946711. PubMed ID: 34336094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]